Metraipolis › archive › dc_2bc357ce1db0

Immunotherapy of chimeric antigen receptor NK cells: status and its promising future — Europe PMC PMID:41246355

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41246355
DOI
10.3389/fimmu.2025.1608277
License (as archived)
solo-consultazione
Archived
2026-11-08T22:46:17.344Z
SHA-256 of the archived text
fefc8bc7c6089ae28b508bdec19a03636987bf6b8469788b307dd68cc55eb0a7
Stable URL of this page
https://metraipolis.com/documento/dc_2bc357ce1db0

How to cite

Immunotherapy of chimeric antigen receptor NK cells: status and its promising future — Europe PMC PMID:41246355 — Europe PMC (en), https://europepmc.org/article/MED/41246355 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bc357ce1db0 (Metraipolis archive dc_2bc357ce1db0, sha256 fefc8bc7c6089ae28b508bdec19a03636987bf6b8469788b307dd68cc55eb0a7)
BibTeX
@misc{dc2bc357ce1db0,
  title = {Immunotherapy of chimeric antigen receptor NK cells: status and its promising future — Europe PMC PMID:41246355},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41246355},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bc357ce1db0; sha256 fefc8bc7c6089ae28b508bdec19a03636987bf6b8469788b307dd68cc55eb0a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41246355. Agents can read the archived copy with the MCP tool read_document.